Achieve Life Sciences, Inc. key statistics and ratios

In fiscal 2019, Achieve Life Sciences, Inc. had return on equity of -96.9%, debt equal to 0.0% of equity and a current ratio of 6.04. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Achieve Life Sciences, Inc.: financial ratios, annual
Fiscal year	2018Dec 2018	2019Dec 2019
Return on equity	−80.3%	−96.9%
Return on assets	−66.5%	−81.6%
Current ratio	4.75	6.04
Debt to equity	0.0%	0.0%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Achieve Life Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Achieve Life Sciences, Inc.